The L-Arginine (Arg) auxotrophic cancerous cells like hepatocellular carcinoma, human colon cancer, leukemia, and breast cancer cells were sensitive to Arg depriving enzymes treatment due to low expression of crucial enzymes argininosuccinate synthetase, argininosuccinate lyase, and ornithine transcarbamylase.
[Cancer Chemotherapy and Pharmacology]
6445218 {6445218:U9743V57} apa 50 1 165102 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b29f48a066691a381c89bce716493882%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22U9743V57%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kumari%20and%20Bansal%22%2C%22parsedDate%22%3A%222021-07-26%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKumari%2C%20N.%2C%20%26amp%3B%20Bansal%2C%20S.%20%282021%29.%20Arginine%20depriving%20enzymes%3A%20applications%20as%20emerging%20therapeutics%20in%20cancer%20treatment.%20%3Ci%3ECancer%20Chemotherapy%20and%20Pharmacology%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00280-021-04335-w%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00280-021-04335-w%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DU9743V57%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Arginine%20depriving%20enzymes%3A%20applications%20as%20emerging%20therapeutics%20in%20cancer%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neha%22%2C%22lastName%22%3A%22Kumari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saurabh%22%2C%22lastName%22%3A%22Bansal%22%7D%5D%2C%22abstractNote%22%3A%22Cancer%20is%20the%20second%20leading%20cause%20of%20death%20globally.%20Chemotherapy%20and%20radiation%20therapy%20and%20other%20medications%20are%20employed%20to%20treat%20various%20types%20of%20cancer.%20However%2C%20each%20treatment%20has%20its%20own%20set%20of%20side%20effects%2C%20owing%20to%20its%20low%20specificity.%20As%20a%20result%2C%20there%20is%20an%20urgent%20need%20for%20newer%20therapeutics%20that%20do%20not%20disrupt%20healthy%20cells%5Cu2019%20normal%20functioning.%20Depriving%20nutrient%20or%20non%5C%2Fsemi-essential%20amino%20acids%20to%20which%20cancerous%20cells%20are%20auxotrophic%20remains%20one%20such%20promising%20anticancer%20strategy.%20l-Arginine%20%28Arg%29%20is%20a%20semi-essential%20vital%20amino%20acid%20involved%20in%20versatile%20metabolic%20processes%2C%20signaling%20pathways%2C%20and%20cancer%20cell%20proliferation.%20Hence%2C%20the%20administration%20of%20Arg%20depriving%20enzymes%20%28ADE%29%20such%20as%20arginase%2C%20arginine%20decarboxylase%20%28ADC%29%2C%20and%20arginine%20deiminase%20%28ADI%29%20could%20be%20effective%20in%20cancer%20therapy.%20The%20Arg%20auxotrophic%20cancerous%20cells%20like%20hepatocellular%20carcinoma%2C%20human%20colon%20cancer%2C%20leukemia%2C%20and%20breast%20cancer%20cells%20are%20sensitive%20to%20ADE%20treatment%20due%20to%20low%20expression%20of%20crucial%20enzymes%20argininosuccinate%20synthetase%20%28ASS%29%2C%20argininosuccinate%20lyase%20%28ASL%29%2C%20and%20ornithine%20transcarbamylase%20%28OCT%29.%20These%20therapeutic%20enzyme%20treatments%20induce%20cell%20death%20through%20inducing%20autophagy%2C%20apoptosis%2C%20generation%20of%20oxidative%20species%2C%20i.e.%2C%20oxidative%20stress%2C%20and%20arresting%20the%20progression%20and%20expansion%20of%20cancerous%20cells%20at%20certain%20cell%20cycle%20checkpoints.%20The%20enzymes%20are%20undergoing%20clinical%20trials%20and%20could%20be%20successfully%20exploited%20as%20potential%20anticancer%20agents%20in%20the%20future.%22%2C%22date%22%3A%222021-07-26%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00280-021-04335-w%22%2C%22ISSN%22%3A%221432-0843%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00280-021-04335-w%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-07-28T02%3A49%3A56Z%22%7D%7D%5D%7D
Kumari, N., & Bansal, S. (2021). Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-021-04335-w Cite